Dr. Gerald Diaz @GeraldMD
48.7M 14.2K 7.5K
Board Certified Internal Medicine Hospitalist, GrepMed Editor in Chief 🇵🇭 🇺🇸 - Sign up for an account to like, bookmark and upload images to contribute to our community platform. Follow us on IG: https://www.instagram.com/grepmed/ | Twitter: https://twitter.com/grepmeded/
Contributor Ranks
Latest Searches
11 results
pharmacology inhibitors management agonists aki diagnosis dosing dpp4 injury kidney summary algorithm antidiabetic classification comparison decisionaid differential lidocaine lidoderm oral
Diabetes Medications Summary Table Insulin Lifestyle modifications Metformin Sulfonylureas GLP-1 receptor agonists - ↓ major adverse CV events TZDs DPP-4 inhibitors SGLT2 inhibitors -
Diabetes Medications ... Sulfonylureas GLP ... #medications #table ... comparison #management #endocrinology ... #dm2
Profiles of Antidiabetic Medications - AACE 2018 #Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
of Antidiabetic Medications ... #Antidiabetic #Medications ... #SideEffects #Table ... DecisionAid #Orals #DM2 ... #Diabetes #Endocrinology
GLP-1 Agonists Adlyxin (Lixisenatide) Daily Bydureon (Exenatide ER) Weekly Ozempic (Semaglutide) Weekly Trulicity (Dulaglutide) Weekly Victoza (Liraglutide) Daily
commonly used medications ... to treat Type 2 Diabetes ... mistaken these medications ... injection site pain ... #DM2 #Endocrinology
Acute Kidney Injury (AKI) - Differential Diagnosis Framework Pre-Renal: • Hypovolemia, Cardiorenal, Distributive Shock, HRS, Hypercalcemia, Renal
Acute Kidney Injury ... Compartment Syndrome, Medications ... , DM) SCVMC Internal ... Differential #Diagnosis #nephrology ... #causes #algorithm
GLP-1 Receptor Agonists - Pharmacology Summary Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
GLP-1 Receptor Agonists ... Ozempic), or daily tablet ... not definitively cause ... Pharmacology #Summary #DM2 ... #diabetes #endocrinology
DPP-4 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
normally inactivates GLP ... Toxicities: • Joint pains ... not definitively cause ... Pharmacology #Summary #DM2 ... #diabetes #endocrinology
SGLT2 Inhibitors SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
medications, with ... kidney), which causes ... #Pharmacology #Medications ... #DM2 #Diabetes ... #Endocrinology
DPP4 Inhibitors - Normal and Renal Dosing Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Increase Incretins (GLP-I ... different than other medications ... very tolerable medication ... Pharmacology #Management #Diabetes ... #DM2 #Endocrinology
Acute Kidney Injury - Classification Prerenal: • Dehydration • Heart failure (a.k.a. cardiorenal syndrome) • Liver failure
Acute Kidney Injury ... tubular necrosis (causes ... interstitial nephritis (AIN ... tract infection • Medications ... Classification #diagnosis #nephrology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist Dosing: 3 mg daily x 30 days, then 7 mg
semaglutide, the same medication ... drug to remain stable ... take any other medications ... #semaglutide #Diabetes ... #Pharmacology #Endocrinology
empty